Martyna Popis

Immunology and Microbiology · Life Sciences

6h-index1.4kcitations25works0.52yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immune Cell Function and Interaction(15), Cell death mechanisms and regulation(9), NF-κB Signaling Pathways(9), CAR-T cell therapy research(7), RNA modifications and cancer(4)

Publications25 total

Figure S4 from The Allogeneic FAP-CAR-IL15 iNKT Therapy MiNK-215 Remodels the Tumor Stroma to Enhance Antitumor Immunity
2026Open Access
Data from The Allogeneic FAP-CAR-IL15 iNKT Therapy MiNK-215 Remodels the Tumor Stroma to Enhance Antitumor Immunity
2026Open Access
Figure S1 from The Allogeneic FAP-CAR-IL15 iNKT Therapy MiNK-215 Remodels the Tumor Stroma to Enhance Antitumor Immunity
2026Open Access
Table S2 from The Allogeneic FAP-CAR-IL15 iNKT Therapy MiNK-215 Remodels the Tumor Stroma to Enhance Antitumor Immunity
2026Open Access
Figure S2 from The Allogeneic FAP-CAR-IL15 iNKT Therapy MiNK-215 Remodels the Tumor Stroma to Enhance Antitumor Immunity
2026Open Access
Figure S3 from The Allogeneic FAP-CAR-IL15 iNKT Therapy MiNK-215 Remodels the Tumor Stroma to Enhance Antitumor Immunity
2026Open Access
Figure S6 from The Allogeneic FAP-CAR-IL15 iNKT Therapy MiNK-215 Remodels the Tumor Stroma to Enhance Antitumor Immunity
2026Open Access
Table S3 from The Allogeneic FAP-CAR-IL15 iNKT Therapy MiNK-215 Remodels the Tumor Stroma to Enhance Antitumor Immunity
2026Open Access
Table S1 from The Allogeneic FAP-CAR-IL15 iNKT Therapy MiNK-215 Remodels the Tumor Stroma to Enhance Antitumor Immunity
2026Open Access
Figure S7 from The Allogeneic FAP-CAR-IL15 iNKT Therapy MiNK-215 Remodels the Tumor Stroma to Enhance Antitumor Immunity
2026Open Access
Figure S8 from The Allogeneic FAP-CAR-IL15 iNKT Therapy MiNK-215 Remodels the Tumor Stroma to Enhance Antitumor Immunity
2026Open Access
Figure S5 from The Allogeneic FAP-CAR-IL15 iNKT Therapy MiNK-215 Remodels the Tumor Stroma to Enhance Antitumor Immunity
2026Open Access
The Allogeneic FAP-CAR-IL15 iNKT Therapy MiNK-215 Remodels the Tumor Stroma to Enhance Antitumor Immunity
Cancer Immunology Research·2025
CAR-iNKT cells: redefining the frontiers of cellular immunotherapy
Frontiers in Immunology·2025· 7 citedOpen Access
753 AgenT-797 cell therapy can be combined with next-generation immune checkpoint inhibitors (ICI) and/or bi-specific engagers to improve anti-cancer response
Regular and Young Investigator Award Abstracts·2024· 1 citedOpen Access
322 MiNK-413: a next generation armored allogenic BCMA CAR iNKT product
Regular and Young Investigator Award Abstracts·2022· 2 citedOpen Access
358 Development of an allogenic FAP CAR iNKT product to target tumor stroma and modulate the tumor microenvironment
Regular and Young Investigator Award Abstracts·2022· 2 citedOpen Access
135 Identification and characterization of an allogeneic iNKT-CAR targeting BCMA
Regular and Young Investigator Award Abstracts·2021Open Access
Canonical Notch signaling controls the early thymic epithelial progenitor cell state and emergence of the medullary epithelial lineage in fetal thymus development
Development·2020· 39 citedOpen Access
Cytosine-5 RNA methylation links protein synthesis to cell metabolism
PLoS Biology·2019· 131 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Paul Ibbett(16), Xavier Michelet(16), Efrat Altman-Sharoni(15), Dhan Chand(15), Reed Masakayan(15), Olivier Le Tonquèze(15), Mark A. Exley(14), Shannon K. Boi(14), Justin G. Keith(14), Jin San Choi(13), Stephanie Sanders(13), Alvaro Sebastian-Yague(13), Moira Pinzan-Rossi(13), Georgios Antonopoulos(13), Deborah Wright(13), Nick Kushner(13), Kah Teong Soh(13), Vignesh Venkatraman(13), John Pravin(13), Priyadarshini Iyer(13)